Alcohol, estrogen replacement therapy, and visuospatial processes in postmenopausal women

Alcoholism: Clinical and Experimental Research

Volumn 27, Issue 7, 2003, Pages 1055-1063

  Tivis, Laura J ^a   Green, Michelle D ^b   Nixon, Sara Jo ^b   Tivis, Rick D ^b  

^a Okla Cent Alcohol/Drug Rel Stud   (United States)

^b NONE

Author keywords

Moderate Drinking; Postmenopausal Women; Visuospatial Functioning

Indexed keywords

ALCOHOL; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MEDROXYPROGESTERONE; NORETHISTERONE ACETATE; PIPERAZINE ESTRONE SULFATE;

ADULT; AGED; ALCOHOL CONSUMPTION; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; COGNITION; DEPTH PERCEPTION; DRINKING BEHAVIOR; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; INTELLIGENCE TEST; INTERVIEW; MAJOR CLINICAL STUDY; METHODOLOGY; PERFORMANCE; PHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; SCORING SYSTEM;

AGED; ALCOHOL DRINKING; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; INTERVIEWS; MIDDLE AGED; POSTMENOPAUSE; PSYCHOMOTOR PERFORMANCE; WECHSLER SCALES;

EID: 0037698626     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ALC.0000075545.28199.DF     Document Type: Article

References (72)

1. Adams KM, Brown GG, Grant I (1985) Analysis of covariance as a remedy for demographic mismatch of research subjects groups: some sobering simulations. J Clin Exp Neuropsychol 7:445-462.
2. Barrett-Connor E, Kritz-Silverstein D (1993) Estrogen replacement therapy and cognitive function in older women. JAMA 269:2637-2641.
3. Beatty WW, Hames KA, Blanco CR, Nixon SJ, Tivis LJ (1996) Visuospatial perception, construction and memory in alcoholism. J Stud Alcohol 57:136-143.
4. Beck AT, Steer RA, Garbin MG (1988) Psychometric properties of the Beck depression inventory: twenty-five years of evaluation. Clin Psychol Rev 8:77-100.
5. Cahalan D, Cisin I, Crossley HM (1969) American Drinking Practices: A National Study of Drinking Behaviors and Attitudes (Monograph No. 6). Rutgers Center of Alcohol Studies, New Brunswick, NJ.
6. Caldwell BM, Watson RI (1952) An evaluation of psychologic effects of sex hormone administration in aged women. J Gerontol 7:228-244.
7. Campbell S, Whitehead M (1977) Oestrogen therapy and the menopausal syndrome. Clin Obstet Gynaecol 4:31-47.
8. Cauley JA, Gutal JP, Kuller LH, LeDonne D, Powell JG (1989) The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol 129:1120-1131.
9. Cervilla JA, Prince M, Mann A (2000) Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry 68:622-626.
10. Dufouil C, Ducimetiere P, Alperovitch A (1997) Sex differences in the association between alcohol consumption and cognitive performance. Am J Epidemiol 146:405-412.
11. Duka T, Tasker R, McGowan JF (2000) The effects of 3-week estrogen hormone replacement on cognition in elderly healthy females. Psychopharmacology 149:129-139.
12. Eckardt MJ, File SE, Gessa GL, Grant KA, Guerri C, Hoffman PL, Kalant H, Koob GF, Li T-K, Tabokoff B (1998) Effects of moderate alcohol consumption on the central nervous system. Alcohol Clin Exp Res 22:998-1040.
13. Elias PK, Elias MF, D'Agostino RB, Silbershatz H, Wolf PA (1999) Alcohol consumption and cognitive performance in the Framingham Heart Study. Am J Epidemiol 150:580-589.
14. Fedor-Freybergh P (1977) The influence of oestrogens on the wellbeing and mental performance in climacteric and postmenopausal women. Acta Obstet Gynecol Scand Suppl 64:5-69.
15. Gavaler JS, Deal SR, Van Thiel DH, Arria A, Allan MJ (1993) Alcohol and estrogen levels in postmenopausal women: the spectrum of effect. Alcohol Clin Exp Res 17:786-790.
16. Ginsburg ES (1999) Estrogen, alcohol and breast cancer risk. J Steroid Biochem Mol Biol 69:299-306.
17. Ginsburg ES, Mello NK, Mendelson JH, Barbieri RL, Teoh SK, Rothman M, Gao X, Sholar JW (1996) Effects of alcohol ingestion on estrogens in postmenopausal women. JAMA 276:1747-1751.
18. Ginsburg ES, Walsh BW, Shea BF, Gao X, Gleason RE, Barbieri RL (1995) The effects of ethanol on the clearance of estradiol in postmenopausal women. Fertil Steril 63:1227-1230.
19. Hackman BW, Galbraith D (1976) Replacement therapy with piperazine oestrone sulphate ("Harmogen") and its effect on memory. Curr Med Res Opin 4:303-306.
20. Hampson E (1990) Variations in sex-related cognitive abilities across the menstrual cycle. Brain Cogn 14:26-43.
21. Hampson E (1995) Spatial cognition in humans: possible modulation by androgens and estrogens. J Psychiatry Neurosci 20:397-404.
22. Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GZ, Stampfer MJ, Longscope C, Speizer FE (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 87:1297-1302.
23. Haskell SG, Richardson ED, Horwitz RI (1997) The effect of estrogen replacement therapy on cognitive function in women: a critical review of the literature. J Clin Epidemiol 50:1249-1264.
24. Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, McCleary CA, Klein RA, Hake AM, Farlow MR (2000) Estrogen for Alzheimer's disease in women: randomized, double-blind, placebo-controlled trial. Neurology 54:295-301.
25. Hollingshead AB (1975) Four-Factor Index Of Social Status. Department of Sociology, Yale University, New Haven, CT.
26. Holst J, Backstrom T, Hammarback S, von Schoultz B (1989) Progestogen addition during oestrogen replacement therapy - effects on vasomotor symptoms and mood. Maturitas 11:13-20.
27. Jacobs SM, Tang M-X, Stern Y, Sano M, Marder K, Bell KL, Schofield P, Dooneief G, Gurland B, Mayeux R (1998) Cognitive function in non-demented older women who took estrogen after menopause. Neurology 50:368-373.
28. Kampen DL, Sherwin BB (1994) Estrogen use and verbal memory in healthy postmenopausal women. Obstet Gynecol 83:979-983.
29. Kaplan E (1988) A process approach to neuropsychological assessment, in Clinical Neuropsychology and Brain Functioning: Research, Measurement and Practice (Boll T, Bryant BK eds), pp 125-167. American Psychological Association, Washington, DC.
30. Kaplan E, Fein D, Morris R, Delis D (1991) WAIS-R NI Manual. The Psychological Corporation, Harcourt Brace Jovanovich Inc, San Antonio, TX.
31. Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, Bacal C, Donnell Lingle D, Metter E (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Obstet Gynecol Surv 52:694-695.
32. Keenan PA, Ezzat WH, Ginsburg K, Moore GJ (2001) Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 26:577-590.
33. Kimura D (1995) Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm Behav 29:312-321.
34. Kramer JH, Blusewicz MJ, Robertsons LC, Preston K (1989) Effects of chronic alcoholism on perception of hierarchical visual stimuli. Alcohol Clin Exp Res 13:240-244.
35. London S, Willett W, Longcope C, McKinlay S (1991) Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am J Clin Nutr 53:166-171.
36. Maki PM, Resnick SM (2000) Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol Aging 21:373-383.
37. McEwen BS (1999) Clinical review 108: the molecular and neuroanatomical basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 84:1790-1797.
38. Miller WR (1996) Form 90: A Structured Assessment Interview for Drinking and Related Behaviors Test Manual (Project MATCH Monograph Series). Vol 5. National Institute on Alcohol Abuse and Alcoholism, Department of Health and Human Services, Bethesda, MD.
39. Mulnard RA, Cotman CW, Kawas C, van Dyck CH, Sano M, Doody R, Koss E, Pfeiffer E, Jin S, Gamst A, Grundman M, Thomas R, Thal LJ, for the Alzheimer's Disease Cooperative Study (2000) Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. JAMA 283:1007-1015.
40. Munro CA, Saxton J, Butters MA (2000) The neuropsychological consequences of abstinence among older alcoholics: a cross-sectional study. Alcohol Clin Exp Res 24:1510-1516.
41. Newman AB (1999) Cognitive performance and estrogen use in nondemented older women. J Am Geriatr Soc 47:1267-1268.
42. Parsons OA, Leber WR (1982) Alcohol, cognitive dysfunction and brain damage, in Biomedical Processes and Consequences of Alcohol Use (Alcohol and Health Monograph 2). National Institute on Alcohol Abuse and Alcoholism, Rockville, MD.
43. Phillips SM, Sherwin BB (1992) Effects of estrogen on memory function in surgically menopausal women. Psychoneuroendocrinology 17:485-495.
44. Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R (1998) The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet Gynecol 91:459-466.
45. Purohit V (2001) Can alcohol promote aromatization of androgens to estrogens? A review. Alcohol 22:123-127.
46. Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB (1998) Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 34:171-182.
47. Rice MM, Graves AB, McCurry SM, Gibbons LE, Bown JD, McCormick WC, Larson EB (2000) Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: the Kame project. Arch Intern Med 160:1641-1649.
48. Rice MM, Graves AB, McCurry SM, Larson EB (1997) Estrogen replacement therapy and cognitive function in postmenopausal women without dementia. Am J Med 103:26S-35S.
49. Rossouw JE, Anderson GL, Prentice RL, La Croix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288:321-333.
50. Schandler SL, Clegg AD, Thomas CS, Cohen MJ (1996) Visuospatial information processing in intoxicated, recently detoxified, and long-term abstinent alcoholics. J Subst Abuse 8:321-333.
51. Schneider LS, Farlow MR, Pogoda JM (1997) Potential role for estrogen replacement in the treatment of Alzheimer's dementia. Am J Med (Suppl 3A) 103:46S-50S.
52. Senanarong V, Vannasaeng S, Poungvarin N, Ploybutr S, Udompunthurak S, Jamjumras P, Fairbanks L, Cummings JL (2002) Endogenous estradiol in elderly individuals. Arch Neurol 59:385-389.
53. Sharts-Hopko NC (2001) Hysterectomy for nonmalignant conditions: more than 25% of women have a hysterectomy by the time they reach age 60, yet fewer than 10% of these procedures treat malignant conditions. Are patients informed sufficiently to make the best choice? Am J Nurs 101:32-40.
54. Sherwin BB (1988) Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 13:345-357.
55. Sherwin BB (1991) The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 72:336-343.
56. Sherwin BB (1998) Estrogen and cognitive functioning in women. Proc Soc Exp Biol Med 217:17-22.
57. Sherwin BB, Phillips S (1990) Estrogen and cognitive functioning in surgically menopausal women. Ann NY Acad Sci 592:474-475.
58. Shipley WC (1940) A self-administered scale for measuring intellectual impairment and deterioration. J Psychol 9:371-377.
59. Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory. Consulting Psychologists Press Inc, Mind Garden, CA.
60. Stringer AY, Goldman MS (1988) Experience-dependent recovery of block design performance in male alcoholics: strategy training versus unstructured practice. J Stud Alcohol 49:406-411.
61. Sullivan EV, Fama R, Rosenbloom MJ, Pfefferbaum A (2002) A profile of neuropsychological deficits in alcoholic women. Neuropsychology 16:74-83.
62. Sullivan EV, Rosenbloom MJ, Pfefferbaum A (2000) Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 24:611-621.
63. Szklo M, Cerhan J, Diez-Roux AV, Chambless L, Cooper L, Folsom AR, Fried LP, Knopman D, Nieto FJ (1996) Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 144:1048-1057.
64. Tabachnick BG, Fidell LS (2001) Analysis of covariance, in Using Multivariate Statistics (Tabachnick BG, Fidell LS eds), 4th ed, pp 282-283. Allyn and Bacon, Boston.
65. Tivis LJ, Nixon SJ, Green MG (2001) Estrogen replacement therapy: a perspective on cognitive impact. Assessment 8:403-416.
66. Trichopoulos D, Brown J, MacMahon B (1987) Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer 40:721-725.
67. US Department of Agriculture/US Department of Health and Human Services (1990) Nutrition and Your Health: Dietary Guidelines for Americans (Home and Garden Bulletin No. 232). 3rd ed. Government Printing Office, Washington, DC.
68. US Department of Health and Human Services (2000) 10th Special Report to the U.S. Congress on Alcohol and Health: Highlights From Current Research. Public Health Service, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda, MD.
69. Verghese J, Kuslansky G, Katz MJ (2000) Cognitive performance in surgically menopausal women on estrogen. Neurology 55:872-874.
70. Wechsler D (1981) Wechsler Adult Intelligence Scale-Revised Manual. The Psychological Corporation, Harcourt Brace Jovanovich Inc, San Antonio, TX.
71. Wilkinson DA (1987) CT scan and neuropsychological assessments of alcoholism, in Neuropsychology of Alcoholism: Implications for Diagnosis and Treatment (Parsons OA, Butters N, Nathan PE eds), pp 76-102. Guilford Press, New York.
72. Yaffe K, Sawaya G, Lieberburg I, Grady D (1998) Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA 279:688-695.